The drug regulation and approval process is nuanced and complicated. A story has recently emerged that begs questions about the efficacy, judgment, and communication of both drug regulators and pharmaceutical companies. This controversy spans international lines, with American researchers weighing in and British scientists speaking up to share their opinions. Let’s dive in and find…